Futura Medical plc
FUM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £1 | £7 | £7 | £1 |
| % Growth | -85.5% | -1.1% | 400.9% | – |
| Cost of Goods Sold | £1 | £2 | £2 | £1 |
| Gross Profit | £0 | £5 | £5 | £1 |
| % Margin | 24.3% | 69.4% | 68% | 61.9% |
| R&D Expenses | £1 | £1 | £1 | £1 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £6 | £3 | £3 | £5 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£0 | £0 | £0 |
| Operating Expenses | £7 | £4 | £4 | £6 |
| Operating Income | -£7 | £0 | £1 | -£5 |
| % Margin | -671.6% | 4.3% | 11.7% | -358.1% |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | -£7 | £0 | £1 | £0 |
| Tax Expense | -£0 | £0 | -£0 | £5 |
| Net Income | -£7 | £0 | £1 | -£5 |
| % Margin | -657.8% | 4.2% | 14.3% | -340% |
| EPS | -0.022 | 0.001 | 0.003 | -0.016 |
| % Growth | -2,270% | -69.7% | 120.2% | – |
| EPS Diluted | -0.022 | 0.001 | 0.003 | -0.016 |
| Weighted Avg Shares Out | 304 | 291 | 302 | 292 |
| Weighted Avg Shares Out Dil | 304 | 291 | 317 | 292 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£7 | £0 | £1 | -£5 |
| % Margin | -661.6% | 7% | 13.2% | -353.5% |